| |
|
|
|
Oramed Pharmaceuticals Inc.  
|
|
4.27 -0.05 (-0.01%) |
10-17 14:20 |
|
Open: |
4.33 |
Pre close: |
4.32 |
Target:
|
5.50
|
|
High: |
4.3543 |
Low: |
4.27 |
Resistance:
|
4.71
5.05
|
|
Volume: |
16,702 |
Market Cap: |
74M |
Support:
|
4.15
3.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.38
 |
MACD |
MACD(12,26):
|
-0.15  |
|
MA(20): |
4.68 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
5.68 |
Stochastic Oscillator |
%K(14,3):
|
25.11 |
|
MA(250): |
7.10 |
%D(3): |
25.05 |
|
Average Volume(K) |
3-Month: |
3528
|
52-Week |
High:
|
10.97 |
|
10-Days: |
3583 |
Low: |
4.15 |
|
RSI |
RSI(14):
|
36.28 |
Change(%): |
-59.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.880 |
Return on Equity (ttm) |
-67.0 |
Shares Out. (M) |
17.36 |
|
EPS Est. Current Year |
-0.780 |
Return on Assets (ttm) |
-32.8 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.270 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
17.70 |
|
Forward EPS |
-1.521 |
Gross Profit (p.s.) |
0.035 |
Shares Short (K) |
284 |
|
Book Value (p.s.) |
4.490 |
EBITDA (p.s.) |
-0.145 |
P/E |
-4.93 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.06 |
P/S |
443190592.00 |
|
Operating Margin |
-540.00 |
Levered Free Cash Flow
(M) |
-5.57 |
P/CF |
-6.25 |
|
|
|
|
|
|
